FibroBiologics, Inc. Common Stock

NASDAQ (USD): FibroBiologics, Inc. Common Stock (FBLG)

Last Price

2.22

Today's Change

-0.05 (2.20%)

Day's Change

2.02 - 2.28

Trading Volume

157,636

Overview

Market Cap

76 Million

Shares Outstanding

34 Million

Avg Volume

231,414

Avg Price (50 Days)

2.80

Avg Price (200 Days)

5.96

PE Ratio

-4.11

EPS

-0.54

Earnings Announcement

26-Feb-2025

Previous Close

2.27

Open

2.20

Day's Range

2.0203 - 2.2821

Year Range

1.078 - 46.0

Trading Volume

157,636

Price Change Highlight

1 Day Change

-2.20%

5 Day Change

-10.12%

1 Month Change

-21.00%

3 Month Change

-31.90%

6 Month Change

-68.78%

Ytd Change

-92.37%

1 Year Change

-92.37%

3 Year Change

-92.37%

5 Year Change

-92.37%

10 Year Change

-92.37%

Max Change

-92.37%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

FibroBiologics, Inc., a clinical-stage cell therapy company, develops and commercializes fibroblast-based therapies in the United States. It is developing CybroCell, for the treatment of degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for wound healing. The company is also on the early-stage research of CYTER915, which is designed to regenerate or reinvigorate production of the thymus and/or spleen; CYPS317, for the treatment of psoriasis; and TCB190 to treat certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment